TP53 and breast cancer: There are, however, still unresolved issues surrounding the development of p53 as a therapeutic target [177], with diseases, such as breast cancer, not benefiting from p53 inhibition, possibly in part due to the vast heterogeneity of the disease as well as the limited efficacy of targeting transcription factor function.